{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T10:21:49Z","timestamp":1794997309156,"version":"4.9.1"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T00:00:00Z","timestamp":1588896000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T00:00:00Z","timestamp":1588896000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000069","name":"U.S. Department of Health & Human Services | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["R01AR068983"],"award-info":[{"award-number":["R01AR068983"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"U.S. Department of Health & Human Services | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["R21AR072836"],"award-info":[{"award-number":["R21AR072836"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"U.S. Department of Health & Human Services | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["R21AR073331"],"award-info":[{"award-number":["R21AR073331"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"name":"U.S. Department of Health & Human Services | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases"},{"name":"U.S. Department of Health & Human Services | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases"},{"DOI":"10.13039\/100000861","name":"Burroughs Wellcome Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000861","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["NF150055"],"award-info":[{"award-number":["NF150055"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000093","name":"March of Dimes Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000093","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The osteoblast differentiation capacity of skeletal stem cells (SSCs) must be tightly regulated, as inadequate bone formation results in low bone mass and skeletal fragility, and over-exuberant osteogenesis results in heterotopic ossification (HO) of soft tissues. RUNX2 is essential for tuning this balance, but the mechanisms of posttranslational control of RUNX2 remain to be fully elucidated. Here, we identify that a CK2\/HAUSP pathway is a key regulator of RUNX2 stability, as Casein kinase 2 (CK2) phosphorylates RUNX2, recruiting the deubiquitinase herpesvirus-associated ubiquitin-specific protease (HAUSP), which stabilizes RUNX2 by diverting it away from ubiquitin-dependent proteasomal degradation. This pathway is important for both the commitment of SSCs to osteoprogenitors and their subsequent maturation. This CK2\/HAUSP\/RUNX2 pathway is also necessary for HO, as its inhibition blocked HO in multiple models. Collectively, active deubiquitination of RUNX2 is required for bone formation and this CK2\/HAUSP deubiquitination pathway offers therapeutic opportunities for disorders of inappropriate mineralization.<\/jats:p>","DOI":"10.1038\/s41467-020-16038-6","type":"journal-article","created":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T10:03:33Z","timestamp":1588932213000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":90,"title":["A RUNX2 stabilization pathway mediates physiologic and pathologic bone formation"],"prefix":"10.1038","volume":"11","author":[{"given":"Jung-Min","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeon-Suk","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kwang Hwan","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianpeng","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6578-4553","authenticated-orcid":false,"given":"Ren","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minkyung","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyunho","family":"Chun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seoyeon","family":"Bok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5875-314X","authenticated-orcid":false,"given":"Julia F.","family":"Charles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1964-7958","authenticated-orcid":false,"given":"Odile","family":"Filhol-Cochet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigitte","family":"Boldyreff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Dinter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2145-4944","authenticated-orcid":false,"given":"Paul B.","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Kon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1480-2368","authenticated-orcid":false,"given":"Wei","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2363-7704","authenticated-orcid":false,"given":"Takeshi","family":"Takarada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew B.","family":"Greenblatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4947-3293","authenticated-orcid":false,"given":"Jae-Hyuck","family":"Shim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,5,8]]},"reference":[{"key":"16038_CR1","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/S0092-8674(00)80258-5","volume":"89","author":"T Komori","year":"1997","unstructured":"Komori, T. et al. Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 89, 755\u2013764 (1997).","journal-title":"Cell"},{"key":"16038_CR2","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1016\/S0092-8674(00)80257-3","volume":"89","author":"P Ducy","year":"1997","unstructured":"Ducy, P., Zhang, R., Geoffroy, V., Ridall, A. L. & Karsenty, G. Osf2\/Cbfa1: a transcriptional activator of osteoblast differentiation. Cell 89, 747\u2013754 (1997).","journal-title":"Cell"},{"key":"16038_CR3","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.cell.2014.12.002","volume":"160","author":"CK Chan","year":"2015","unstructured":"Chan, C. K. et al. Identification and specification of the mouse skeletal stem cell. Cell 160, 285\u2013298 (2015).","journal-title":"Cell"},{"key":"16038_CR4","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.cell.2018.07.029","volume":"175","author":"CKF Chan","year":"2018","unstructured":"Chan, C. K. F. et al. Identification of the human skeletal stem cell. Cell 175, 43\u201356 e21 (2018).","journal-title":"Cell"},{"key":"16038_CR5","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1242\/dev.128793","volume":"143","author":"T Takarada","year":"2016","unstructured":"Takarada, T. et al. Genetic analysis of Runx2 function during intramembranous ossification. Development 143, 211\u2013218 (2016).","journal-title":"Development"},{"key":"16038_CR6","first-page":"177","volume":"36","author":"S Mundlos","year":"1999","unstructured":"Mundlos, S. Cleidocranial dysplasia: clinical and molecular genetics. J. Med Genet 36, 177\u2013182 (1999).","journal-title":"J. Med Genet"},{"key":"16038_CR7","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1016\/S0092-8674(00)80259-7","volume":"89","author":"F Otto","year":"1997","unstructured":"Otto, F. et al. Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development. Cell 89, 765\u2013771 (1997).","journal-title":"Cell"},{"key":"16038_CR8","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.bone.2009.08.057","volume":"46","author":"L Lin","year":"2010","unstructured":"Lin, L., Shen, Q., Xue, T. & Yu, C. Heterotopic ossification induced by Achilles tenotomy via endochondral bone formation: expression of bone and cartilage related genes. Bone 46, 425\u2013431 (2010).","journal-title":"Bone"},{"key":"16038_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2016.325","volume":"7","author":"B Tu","year":"2016","unstructured":"Tu, B. et al. miR-203 inhibits the traumatic heterotopic ossification by targeting Runx2. Cell Death Dis. 7, e2436 (2016).","journal-title":"Cell Death Dis."},{"key":"16038_CR10","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1038\/mt.2011.101","volume":"19","author":"L Lin","year":"2011","unstructured":"Lin, L. et al. Synergistic inhibition of endochondral bone formation by silencing Hif1alpha and Runx2 in trauma-induced heterotopic ossification. Mol. Ther. 19, 1426\u20131432 (2011).","journal-title":"Mol. Ther."},{"key":"16038_CR11","doi-asserted-by":"publisher","first-page":"R144","DOI":"10.1186\/ar3458","volume":"13","author":"K Uchida","year":"2011","unstructured":"Uchida, K. et al. Ossification process involving the human thoracic ligamentum flavum: role of transcription factors. Arthritis Res Ther. 13, R144 (2011).","journal-title":"Arthritis Res Ther."},{"key":"16038_CR12","doi-asserted-by":"publisher","first-page":"32533","DOI":"10.1074\/jbc.M109.040980","volume":"284","author":"C Ge","year":"2009","unstructured":"Ge, C. et al. Identification and functional characterization of ERK\/MAPK phosphorylation sites in the Runx2 transcription factor. J. Biol. Chem. 284, 32533\u201332543 (2009).","journal-title":"J. Biol. Chem."},{"key":"16038_CR13","doi-asserted-by":"publisher","first-page":"2457","DOI":"10.1172\/JCI42285","volume":"120","author":"MB Greenblatt","year":"2010","unstructured":"Greenblatt, M. B. et al. The p38 MAPK pathway is essential for skeletogenesis and bone homeostasis in mice. J. Clin. Investig 120, 2457\u20132473 (2010).","journal-title":"J. Clin. Investig"},{"key":"16038_CR14","doi-asserted-by":"publisher","first-page":"16502","DOI":"10.1074\/jbc.M512494200","volume":"281","author":"EJ Jeon","year":"2006","unstructured":"Jeon, E. J. et al. Bone morphogenetic protein-2 stimulates Runx2 acetylation. J. Biol. Chem. 281, 16502\u201316511 (2006).","journal-title":"J. Biol. Chem."},{"key":"16038_CR15","doi-asserted-by":"publisher","first-page":"27939","DOI":"10.1074\/jbc.M304132200","volume":"278","author":"M Zhao","year":"2003","unstructured":"Zhao, M., Qiao, M., Oyajobi, B. O., Mundy, G. R. & Chen, D. E3 ubiquitin ligase Smurf1 mediates core-binding factor alpha1\/Runx2 degradation and plays a specific role in osteoblast differentiation. J. Biol. Chem. 278, 27939\u201327944 (2003).","journal-title":"J. Biol. Chem."},{"key":"16038_CR16","doi-asserted-by":"publisher","first-page":"4326","DOI":"10.1074\/jbc.M509430200","volume":"281","author":"H Kaneki","year":"2006","unstructured":"Kaneki, H. et al. Tumor necrosis factor promotes Runx2 degradation through up-regulation of Smurf1 and Smurf2 in osteoblasts. J. Biol. Chem. 281, 4326\u20134333 (2006).","journal-title":"J. Biol. Chem."},{"key":"16038_CR17","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1126\/science.1126313","volume":"312","author":"DC Jones","year":"2006","unstructured":"Jones, D. C. et al. Regulation of adult bone mass by the zinc finger adapter protein Schnurri-3. Science 312, 1223\u20131227 (2006).","journal-title":"Science"},{"key":"16038_CR18","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1038\/nature737","volume":"416","author":"M Li","year":"2002","unstructured":"Li, M. et al. Deubiquitination of p53 by HAUSP is an important pathway for p53 stabilization. Nature 416, 648\u2013653 (2002).","journal-title":"Nature"},{"key":"16038_CR19","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1016\/S1097-2765(04)00157-1","volume":"13","author":"M Li","year":"2004","unstructured":"Li, M., Brooks, C. L., Kon, N. & Gu, W. A dynamic role of HAUSP in the p53-Mdm2 pathway. Mol. Cell 13, 879\u2013886 (2004).","journal-title":"Mol. Cell"},{"key":"16038_CR20","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1128\/MCB.00639-13","volume":"34","author":"M Jagannathan","year":"2014","unstructured":"Jagannathan, M. et al. A role for USP7 in DNA replication. Mol. Cell Biol. 34, 132\u2013145 (2014).","journal-title":"Mol. Cell Biol."},{"key":"16038_CR21","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1096\/fj.02-0473rev","volume":"17","author":"F Meggio","year":"2003","unstructured":"Meggio, F. & Pinna, L. A. One-thousand-and-one substrates of protein kinase CK2? FASEB J. 17, 349\u2013368 (2003).","journal-title":"FASEB J."},{"key":"16038_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1042\/bj20021469","volume":"369","author":"DW Litchfield","year":"2003","unstructured":"Litchfield, D. W. Protein kinase CK2: structure, regulation and role in cellular decisions of life and death. Biochem J. 369, 1\u201315 (2003).","journal-title":"Biochem J."},{"key":"16038_CR23","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/S0962-8924(02)02279-1","volume":"12","author":"K Ahmed","year":"2002","unstructured":"Ahmed, K., Gerber, D. A. & Cochet, C. Joining the cell survival squad: an emerging role for protein kinase CK2. Trends Cell Biol. 12, 226\u2013230 (2002).","journal-title":"Trends Cell Biol."},{"key":"16038_CR24","doi-asserted-by":"publisher","first-page":"5320","DOI":"10.1093\/emboj\/20.19.5320","volume":"20","author":"K Niefind","year":"2001","unstructured":"Niefind, K., Guerra, B., Ermakowa, I. & Issinger, O. G. Crystal structure of human protein kinase CK2: insights into basic properties of the CK2 holoenzyme. EMBO J. 20, 5320\u20135331 (2001).","journal-title":"EMBO J."},{"key":"16038_CR25","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1038\/70033","volume":"6","author":"K Niefind","year":"1999","unstructured":"Niefind, K., Putter, M., Guerra, B., Issinger, O. G. & Schomburg, D. GTP plus water mimic ATP in the active site of protein kinase CK2. Nat. Struct. Biol. 6, 1100\u20131103 (1999).","journal-title":"Nat. Struct. Biol."},{"key":"16038_CR26","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1128\/MCB.01119-07","volume":"28","author":"DY Lou","year":"2008","unstructured":"Lou, D. Y. et al. The alpha catalytic subunit of protein kinase CK2 is required for mouse embryonic development. Mol. Cell Biol. 28, 131\u2013139 (2008).","journal-title":"Mol. Cell Biol."},{"key":"16038_CR27","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1016\/j.bpj.2010.04.070","volume":"99","author":"B Bragdon","year":"2010","unstructured":"Bragdon, B. et al. Casein kinase 2 beta-subunit is a regulator of bone morphogenetic protein 2 signaling. Biophys. J. 99, 897\u2013904 (2010).","journal-title":"Biophys. J."},{"key":"16038_CR28","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1007\/s10059-013-0184-9","volume":"36","author":"YH Son","year":"2013","unstructured":"Son, Y. H., Moon, S. H. & Kim, J. The protein kinase 2 inhibitor CX-4945 regulates osteoclast and osteoblast differentiation in vitro. Mol. Cells 36, 417\u2013423 (2013).","journal-title":"Mol. Cells"},{"key":"16038_CR29","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1002\/jor.22500","volume":"32","author":"X Liu","year":"2014","unstructured":"Liu, X. et al. A novel mouse model of trauma induced heterotopic ossification. J. Orthop. Res 32, 183\u2013188 (2014).","journal-title":"J. Orthop. Res"},{"key":"16038_CR30","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/sj.sc.3101309","volume":"40","author":"AA van Kuijk","year":"2002","unstructured":"van Kuijk, A. A., Geurts, A. C. & van Kuppevelt, H. J. Neurogenic heterotopic ossification in spinal cord injury. Spinal Cord. 40, 313\u2013326 (2002).","journal-title":"Spinal Cord."},{"key":"16038_CR31","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1177\/0269215507075260","volume":"21","author":"HT Hendricks","year":"2007","unstructured":"Hendricks, H. T., Geurts, A. C., van Ginneken, B. C., Heeren, A. J. & Vos, P. E. Brain injury severity and autonomic dysregulation accurately predict heterotopic ossification in patients with traumatic brain injury. Clin. Rehabil. 21, 545\u2013553 (2007).","journal-title":"Clin. Rehabil."},{"key":"16038_CR32","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.trsl.2017.06.004","volume":"186","author":"D Dey","year":"2017","unstructured":"Dey, D. et al. The traumatic bone: trauma-induced heterotopic ossification. Transl Res. 186, 95\u2013111 (2017).","journal-title":"Transl Res."},{"key":"16038_CR33","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1002\/jbmr.1562","volume":"27","author":"MN Wosczyna","year":"2012","unstructured":"Wosczyna, M. N., Biswas, A. A., Cogswell, C. A. & Goldhamer, D. J. Multipotent progenitors resident in the skeletal muscle interstitium exhibit robust BMP-dependent osteogenic activity and mediate heterotopic ossification. J. Bone Min. Res 27, 1004\u20131017 (2012).","journal-title":"J. Bone Min. Res"},{"key":"16038_CR34","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1084\/jem.20111790","volume":"210","author":"W Zou","year":"2013","unstructured":"Zou, W. et al. The microtubule-associated protein DCAMKL1 regulates osteoblast function via repression of Runx2. J. Exp. Med 210, 1793\u20131806 (2013).","journal-title":"J. Exp. Med"},{"key":"16038_CR35","doi-asserted-by":"publisher","first-page":"E1226","DOI":"10.1073\/pnas.1600813113","volume":"113","author":"MB Greenblatt","year":"2016","unstructured":"Greenblatt, M. B. et al. MEKK2 mediates an alternative beta-catenin pathway that promotes bone formation. Proc. Natl Acad. Sci. USA 113, E1226\u2013E1235 (2016).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"16038_CR36","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/s41586-018-0554-8","volume":"562","author":"S Debnath","year":"2018","unstructured":"Debnath, S. et al. Discovery of a periosteal stem cell mediating intramembranous bone formation. Nature 562, 133\u2013139 (2018).","journal-title":"Nature"},{"key":"16038_CR37","doi-asserted-by":"publisher","first-page":"3247","DOI":"10.1038\/sj.onc.1204411","volume":"20","author":"E Landesman-Bollag","year":"2001","unstructured":"Landesman-Bollag, E. et al. Protein kinase CK2 in mammary gland tumorigenesis. Oncogene 20, 3247\u20133257 (2001).","journal-title":"Oncogene"},{"key":"16038_CR38","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1126\/science.276.5314.952","volume":"276","author":"JK Heriche","year":"1997","unstructured":"Heriche, J. K. et al. Regulation of protein phosphatase 2A by direct interaction with casein kinase 2alpha. Science 276, 952\u2013955 (1997).","journal-title":"Science"},{"key":"16038_CR39","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/ni.3083","volume":"16","author":"A Ulges","year":"2015","unstructured":"Ulges, A. et al. Protein kinase CK2 enables regulatory T cells to suppress excessive TH2 responses in vivo. Nat. Immunol. 16, 267\u2013275 (2015).","journal-title":"Nat. Immunol."},{"key":"16038_CR40","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1128\/MCB.23.3.908-915.2003","volume":"23","author":"T Buchou","year":"2003","unstructured":"Buchou, T. et al. Disruption of the regulatory beta subunit of protein kinase CK2 in mice leads to a cell-autonomous defect and early embryonic lethality. Mol. Cell Biol. 23, 908\u2013915 (2003).","journal-title":"Mol. Cell Biol."},{"key":"16038_CR41","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1002\/gene.10092","volume":"33","author":"M Logan","year":"2002","unstructured":"Logan, M. et al. Expression of Cre Recombinase in the developing mouse limb bud driven by a Prxl enhancer. Genesis 33, 77\u201380 (2002).","journal-title":"Genesis"},{"key":"16038_CR42","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.3390\/ijms20081803","volume":"20","author":"JM Kim","year":"2019","unstructured":"Kim, J. M. et al. The ERK MAPK pathway is essential for skeletal development and homeostasis. Int. J. Mol. Sci. 20, 1803 (2019).","journal-title":"Int. J. Mol. Sci."},{"key":"16038_CR43","doi-asserted-by":"publisher","first-page":"3231","DOI":"10.1242\/dev.02480","volume":"133","author":"SJ Rodda","year":"2006","unstructured":"Rodda, S. J. & McMahon, A. P. Distinct roles for Hedgehog and canonical Wnt signaling in specification, differentiation and maintenance of osteoblast progenitors. Development 133, 3231\u20133244 (2006).","journal-title":"Development"},{"key":"16038_CR44","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1038\/ncb3067","volume":"16","author":"N Ono","year":"2014","unstructured":"Ono, N., Ono, W., Nagasawa, T. & Kronenberg, H. M. A subset of chondrogenic cells provides early mesenchymal progenitors in growing bones. Nat. Cell Biol. 16, 1157\u20131167 (2014).","journal-title":"Nat. Cell Biol."},{"key":"16038_CR45","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1016\/j.febslet.2009.02.040","volume":"583","author":"N Selvamurugan","year":"2009","unstructured":"Selvamurugan, N. et al. Identification and characterization of Runx2 phosphorylation sites involved in matrix metalloproteinase-13 promoter activation. FEBS Lett. 583, 1141\u20131146 (2009).","journal-title":"FEBS Lett."},{"key":"16038_CR46","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s12013-011-9185-5","volume":"60","author":"B Nicholson","year":"2011","unstructured":"Nicholson, B. & Suresh Kumar, K. G. The multifaceted roles of USP7: new therapeutic opportunities. Cell Biochem. Biophys. 60, 61\u201368 (2011).","journal-title":"Cell Biochem. Biophys."},{"key":"16038_CR47","doi-asserted-by":"publisher","first-page":"2354","DOI":"10.1177\/0363546508322886","volume":"36","author":"M Nozaki","year":"2008","unstructured":"Nozaki, M. et al. Improved muscle healing after contusion injury by the inhibitory effect of suramin on myostatin, a negative regulator of muscle growth. Am. J. Sports Med. 36, 2354\u20132362 (2008).","journal-title":"Am. J. Sports Med."},{"key":"16038_CR48","doi-asserted-by":"publisher","first-page":"255ra132","DOI":"10.1126\/scitranslmed.3008810","volume":"6","author":"JR Peterson","year":"2014","unstructured":"Peterson, J. R. et al. Treatment of heterotopic ossification through remote ATP hydrolysis. Sci. Transl. Med 6, 255ra132 (2014).","journal-title":"Sci. Transl. Med"},{"key":"16038_CR49","first-page":"1","volume":"102","author":"JR Peterson","year":"2015","unstructured":"Peterson, J. R. et al. Direct mouse trauma\/burn model of heterotopic ossification. J. Vis. Exp. 102, 1\u20135 (2015).","journal-title":"J. Vis. Exp."},{"key":"16038_CR50","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.ocl.2016.08.009","volume":"48","author":"WR Barfield","year":"2017","unstructured":"Barfield, W. R., Holmes, R. E. & Hartsock, L. A. Heterotopic Ossification in Trauma. Orthop. Clin. North Am. 48, 35\u201346 (2017).","journal-title":"Orthop. Clin. North Am."},{"key":"16038_CR51","doi-asserted-by":"publisher","first-page":"143","DOI":"10.2165\/00002018-200831020-00004","volume":"31","author":"D Layton","year":"2008","unstructured":"Layton, D., Souverein, P. C., Heerdink, E. R., Shakir, S. A. & Egberts, A. C. Evaluation of risk profiles for gastrointestinal and cardiovascular adverse effects in nonselective NSAID and COX-2 inhibitor users: a cohort study using pharmacy dispensing data in The Netherlands. Drug Saf. 31, 143\u2013158 (2008).","journal-title":"Drug Saf."},{"key":"16038_CR52","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/j.1742-7843.2007.00149.x","volume":"102","author":"K Vuolteenaho","year":"2008","unstructured":"Vuolteenaho, K., Moilanen, T. & Moilanen, E. Non-steroidal anti-inflammatory drugs, cyclooxygenase-2 and the bone healing process. Basic Clin. Pharm. Toxicol. 102, 10\u201314 (2008).","journal-title":"Basic Clin. Pharm. Toxicol."},{"key":"16038_CR53","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1007\/s12079-013-0199-1","volume":"7","author":"O Moseychuk","year":"2013","unstructured":"Moseychuk, O. et al. Inhibition of CK2 binding to BMPRIa induces C2C12 differentiation into osteoblasts and adipocytes. J. Cell Commun. Signal 7, 265\u2013278 (2013).","journal-title":"J. Cell Commun. Signal"},{"key":"16038_CR54","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1016\/j.bone.2011.06.037","volume":"49","author":"B Bragdon","year":"2011","unstructured":"Bragdon, B. et al. Casein kinase 2 regulates in vivo bone formation through its interaction with bone morphogenetic protein receptor type Ia. Bone 49, 944\u2013954 (2011).","journal-title":"Bone"},{"key":"16038_CR55","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1172\/JCI82585","volume":"126","author":"K Hu","year":"2016","unstructured":"Hu, K. & Olsen, B. R. Osteoblast-derived VEGF regulates osteoblast differentiation and bone formation during bone repair. J. Clin. Investig 126, 509\u2013526 (2016).","journal-title":"J. Clin. Investig"},{"key":"16038_CR56","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms2313","volume":"3","author":"JM Kim","year":"2012","unstructured":"Kim, J. M. et al. DJ-1 promotes angiogenesis and osteogenesis by activating FGF receptor-1 signaling. Nat. Commun. 3, 1296 (2012).","journal-title":"Nat. Commun."},{"key":"16038_CR57","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1038\/s41591-018-0020-z","volume":"24","author":"R Xu","year":"2018","unstructured":"Xu, R. et al. Targeting skeletal endothelium to ameliorate bone loss. Nat. Med 24, 823\u2013833 (2018).","journal-title":"Nat. Med"},{"key":"16038_CR58","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.cell.2012.01.051","volume":"149","author":"EB Rankin","year":"2012","unstructured":"Rankin, E. B. et al. The HIF signaling pathway in osteoblasts directly modulates erythropoiesis through the production of EPO. Cell 149, 63\u201374 (2012).","journal-title":"Cell"},{"key":"16038_CR59","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/s10456-012-9256-2","volume":"15","author":"D Feng","year":"2012","unstructured":"Feng, D. et al. Protein kinase CK2 is a regulator of angiogenesis in endometriotic lesions. Angiogenesis 15, 243\u2013252 (2012).","journal-title":"Angiogenesis"},{"key":"16038_CR60","doi-asserted-by":"publisher","first-page":"9008","DOI":"10.1093\/nar\/gks687","volume":"40","author":"P Noy","year":"2012","unstructured":"Noy, P., Sawasdichai, A., Jayaraman, P. S. & Gaston, K. Protein kinase CK2 inactivates PRH\/Hhex using multiple mechanisms to de-repress VEGF-signalling genes and promote cell survival. Nucleic Acids Res 40, 9008\u20139020 (2012).","journal-title":"Nucleic Acids Res"},{"key":"16038_CR61","doi-asserted-by":"publisher","first-page":"10288","DOI":"10.1158\/0008-5472.CAN-10-1893","volume":"70","author":"A Siddiqui-Jain","year":"2010","unstructured":"Siddiqui-Jain, A. et al. CX-4945, an orally bioavailable selective inhibitor of protein kinase CK2, inhibits prosurvival and angiogenic signaling and exhibits antitumor efficacy. Cancer Res. 70, 10288\u201310298 (2010).","journal-title":"Cancer Res."},{"key":"16038_CR62","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1111\/j.1749-6632.2009.05238.x","volume":"1192","author":"C Wan","year":"2010","unstructured":"Wan, C. et al. Role of HIF-1alpha in skeletal development. Ann. N. Y Acad. Sci. 1192, 322\u2013326 (2010).","journal-title":"Ann. N. Y Acad. Sci."},{"key":"16038_CR63","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms13885","volume":"7","author":"B Huang","year":"2016","unstructured":"Huang, B. et al. Osteoblasts secrete Cxcl9 to regulate angiogenesis in bone. Nat. Commun. 7, 13885 (2016).","journal-title":"Nat. Commun."},{"key":"16038_CR64","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1038\/cdd.2011.12","volume":"18","author":"N Kon","year":"2011","unstructured":"Kon, N. et al. Roles of HAUSP-mediated p53 regulation in central nervous system development. Cell Death Differ. 18, 1366\u20131375 (2011).","journal-title":"Cell Death Differ."},{"key":"16038_CR65","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1038\/nm.4180","volume":"22","author":"O Tavana","year":"2016","unstructured":"Tavana, O. et al. HAUSP deubiquitinates and stabilizes N-Myc in neuroblastoma. Nat. Med 22, 1180\u20131186 (2016).","journal-title":"Nat. Med"},{"key":"16038_CR66","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1002\/tera.1420220306","volume":"22","author":"MJ McLeod","year":"1980","unstructured":"McLeod, M. J. Differential staining of cartilage and bone in whole mouse fetuses by alcian blue and alizarin red S. Teratology 22, 299\u2013301 (1980).","journal-title":"Teratology"},{"key":"16038_CR67","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1038\/nature12115","volume":"497","author":"T Fukuda","year":"2013","unstructured":"Fukuda, T. et al. Sema3A regulates bone-mass accrual through sensory innervations. Nature 497, 490\u2013493 (2013).","journal-title":"Nature"},{"key":"16038_CR68","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1002\/jbmr.5650020617","volume":"2","author":"AM Parfitt","year":"1987","unstructured":"Parfitt, A. M. et al. Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee. J. Bone Min. Res. 2, 595\u2013610 (1987).","journal-title":"J. Bone Min. Res."},{"key":"16038_CR69","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.ab.2004.02.002","volume":"329","author":"CA Gregory","year":"2004","unstructured":"Gregory, C. A., Gunn, W. G., Peister, A. & Prockop, D. J. An Alizarin red-based assay of mineralization by adherent cells in culture: comparison with cetylpyridinium chloride extraction. Anal. Biochem. 329, 77\u201384 (2004).","journal-title":"Anal. Biochem."},{"key":"16038_CR70","doi-asserted-by":"publisher","first-page":"3309","DOI":"10.1128\/MCB.00358-13","volume":"33","author":"A Dar","year":"2013","unstructured":"Dar, A., Shibata, E. & Dutta, A. Deubiquitination of Tip60 by USP7 determines the activity of the p53-dependent apoptotic pathway. Mol. Cell Biol. 33, 3309\u20133320 (2013).","journal-title":"Mol. Cell Biol."},{"key":"16038_CR71","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29, 15\u201321 (2013).","journal-title":"Bioinformatics"},{"key":"16038_CR72","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1093\/bioinformatics\/btp352","volume":"25","author":"H Li","year":"2009","unstructured":"Li, H. et al. The Sequence Alignment\/Map format and SAMtools. Bioinformatics 25, 2078\u20132079 (2009).","journal-title":"Bioinformatics"},{"key":"16038_CR73","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1093\/bioinformatics\/btu638","volume":"31","author":"S Anders","year":"2015","unstructured":"Anders, S., Pyl, P. T. & Huber, W. HTSeq\u2013a Python framework to work with high-throughput sequencing data. Bioinformatics 31, 166\u2013169 (2015).","journal-title":"Bioinformatics"},{"key":"16038_CR74","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).","journal-title":"Genome Biol."},{"key":"16038_CR75","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/nprot.2008.211","volume":"4","author":"W Huang da","year":"2009","unstructured":"Huang da, W., Sherman, B. T. & Lempicki, R. A. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc. 4, 44\u201357 (2009).","journal-title":"Nat. Protoc."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-16038-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-16038-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-16038-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,5]],"date-time":"2024-08-05T14:52:51Z","timestamp":1722869571000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-16038-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,8]]},"references-count":75,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["16038"],"URL":"https:\/\/doi.org\/10.1038\/s41467-020-16038-6","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,8]]},"assertion":[{"value":"2 March 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"J.H.S. is a scientific founder of the AAVAA Therapeutics and holds equity in this company. Other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2289"}}